Despite some other positive indicators, Twitter's share price fell 14% as the platform revealed a dip in its monthly active users in its second quarter results, compared to the previous quarter.
Facebook sought to blame GDPR as it revealed its daily active users in Europe declined for the first time in nine years and it disappointed investors with lower-than-expected growth.
Novocure and Glue Advertising put on a Facebook Live event promoting the cancer treatment Optune in March.
A WEGO Health white paper examined how the change could affect patient influencers.
Facebook's decision to reprioritise its news feed to favour "social interactions" over other forms of content may please its users but will be challenging for brands.
Digital innovation in Japan, health-tech trends, and social media top the list.
GroupM, the media investment arm of WPP, forecasts global ad growth of 4.3% in 2018, and predicts Google and Facebook will strengthen their stranglehold on digital advertising.
Facebook has formally outlined is advertising policies to its users but the industry feels the internet giant is offloading responsibility instead of stepping up.
Facebook itself has more than six million health-related groups.
Facebook chief operating officer Sheryl Sandberg has said that in turbulent times the social network must do more than simply connect people.
Novartis launches MS study with Apple's ResearchKit; the FDA considering limiting risk info in drug ads; J&J loses baby powder lawsuit
Facebook is ramping up its video offering as a stronger rival to YouTube and Snapchat with the launch of its redesigned video tab.
In only four months, Allergan's unbranded Facebook page for Botox has garnered 32 million brand impressions and 12,000 likes.
To demonstrate the power of goggles equipped with AR and VR, the assistive technology company recreated the event on Facebook Live this weekend.
There are also issues surrounding privacy and legitimacy. According to one expert's research, very few physicians use social media for professional purposes.
The campaign would require a two-fold approach: Facebook link ads and Facebook Audience Network.
Pharmaceutical and healthcare companies use a mix of corporate and brand accounts on Instagram, and some are turning to celebrity influencers.
The Kim Kardashian debacle aside, what makes the platform so potentially valuable to pharma and healthcare marketers is its visual story-telling capability.
A recent CME course using Facebook Live generated 34,000 views and 600 comments.
How VR, nanotechnology, and 3D printing could improve the value of healthcare; 100 experimental therapies in late-stage clinical trials; Kite Pharma plans "controlled" launch of CAR-T therapy
With about 70 million users in six million health-related groups, drugmakers have tremendous opportunity to reach key audiences on Facebook. Here's how.
The organization said it used Facebook to identify participants for a study designed to identify biomarkers associated with Parkinson's disease.
Facebook has found that 43% of people who watch the first three seconds of a video will stay for 10 seconds. To create engagement, agencies need to rethink the creative approach.
Pharma has hidden behind the ability to turn commenting off on Facebook pages, allowing marketers to use the channel much as they would a typical web page.
NPR reports that the move has made Sierra Sandison a type 1 diabetes hero and that users have given the Facebook photo over 4,000 "likes."
The networking site's emotion experiment rankles some in the science and political communities.
The FDA's bad-ad unit took a drugmaker to task for what it calls a misleading Facebook page. History shows the social media surveillance should take no one by surprise.
CDC finds that non-Medicare adults make up the majority of preventable heart attack and stroke cases; a Facebook study shows groups can influence HIV screening; and a Shire ADHD drug gets a "no" from Germany
Among social media channels, healthcare execs are most comfortable with YouTube and least comfortable with Twitter, a survey suggests.
A recent paper shows licensing boards may take action for a professional's behavior regardless of whether it is in the context of a professional setting.